Explore By Subject Area   

How Diabesity is Shaping the World of Self-Injection Devices

Sponsored by Ypsomed

Ian Thompson, VP of Account & Business Development at Ypsomed, addresses the growing challenge of diabesity and how diabetes and obesity influence self-injection device development.

May 13, 2024
How Diabesity is Shaping the World of Self-Injection Devices

Ian Thompson, Vice-President of Account & Business Development at Ypsomed, takes us through the recent history of diabetes and obesity therapeutics, the innovative peptide hormone molecules that have reached the market over the past decades and the equally innovative devices developed to deliver them. He addresses the growing challenge of "diabesity" and shows that diabetes and obesity will continue to influence self-injection device development substantially.


To read the white paper, click this text. 


To learn more about Drug Delivery and the PODD Conference, please visit drug-delivery.org.

In This Article
Sponsors
  • Ypsomed

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.